4.7 Review

Antimicrobial treatment of nosocomial meticillin-resistant Staphylococcus aureus (MRSA) pneumonia: current and future options

期刊

出版社

ELSEVIER
DOI: 10.1016/j.ijantimicag.2010.06.045

关键词

Pneumonia; MRSA; Antimicrobials

资金

  1. Astellas Pharma, Inc.
  2. Pfizer
  3. Wyeth
  4. Johnson Johnson

向作者/读者索取更多资源

Meticillin-resistant Staphylococcus aureus (MRSA) is a frequent cause of nosocomial pneumonia. Inadequate or inappropriate antimicrobial therapy, often caused by antimicrobial resistance, is associated with increased mortality for these infections. Agents currently recommended for the treatment of MRSA pneumonia include vancomycin and linezolid in the USA, and vancomycin, linezolid, teicoplanin and quinupristin/dalfopristin in Europe. Antimicrobials such as tigecycline and daptomycin, although approved for the treatment of some MRSA infections, have not demonstrated efficacy equivalent to the approved agents for MRSA pneumonia. Further agents lack data from randomised controlled trials (e. g. fosfomycin, fusidic acid or rifampicin in combination with vancomycin). Antimicrobial agents that have recently been approved or are being investigated as treatments for MRSA infections include the lipoglycopeptides telavancin (approved for the treatment of complicated skin and skin-structure infections in the USA and Canada), dalbavancin and oritavancin, the cephalosporins ceftobiprole and ceftaroline, and the dihydrofolate reductase inhibitor iclaprim. To be an effective treatment for MRSA pneumonia, antimicrobial agents must have activity against antimicrobial-resistant S. aureus, penetrate well into the lung, have a low potential for resistance development and have a good safety profile. Here, the available data for current and potential future MRSA pneumonia antimicrobials are reviewed and discussed. (C) 2010 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Infectious Diseases

Prospective surveillance study in a 1,400-bed university hospital: COVID-19 exposure at home was the main risk factor for SARS-CoV-2 point seroprevalence among hospital staff

Christina Bahrs, Aurelia Kimmig, Sebastian Weis, Juliane Ankert, Stefan Hagel, Jens Maschmann, Andreas Stallmach, Andrea Steiner, Michael Bauer, Wilhelm Behringer, Michael Baier, Miriam Kesselmeier, Cora Richert, Florian Zepf, Martin Walter, Andre Scherag, Michael Kiehntopf, Bettina Loffler, Mathias W. Pletz

Summary: A prospective cohort study among hospital staff in Jena University Hospital found a low risk of SARS-CoV-2 infection for healthcare workers, possibly due to high compliance in wearing personal protective equipment.

TRANSBOUNDARY AND EMERGING DISEASES (2022)

Article Infectious Diseases

Prediction of COVID-19 deterioration in high-risk patients at diagnosis: an early warning score for advanced COVID-19 developed by machine learning

Carolin E. M. Jakob, Ujjwal Mukund Mahajan, Marcus Oswald, Melanie Stecher, Maximilian Schons, Julia Mayerle, Siegbert Rieg, Mathias Pletz, Uta Merle, Kai Wille, Stefan Borgmann, Christoph D. Spinner, Sebastian Dolff, Clemens Scherer, Lisa Pilgram, Maria Ruethrich, Frank Hanses, Martin Hower, Richard Strauss, Steffen Massberg, Ahmet Gorkem Er, Norma Jung, Joerg Janne Vehreschild, Hans Stubbe, Lukas Tometten, Rainer Koenig

Summary: This study developed a machine learning-based predictor model and a clinical score for identifying patients at risk of progressing to advanced COVID-19, with a focus on better prioritizing patients in need for hospitalization. The predictor model included variables such as temperature, age, body mass index, smoking habit, pulmonary involvement, inflammation markers, and acute kidney injury to predict the disease severity of COVID-19 patients.

INFECTION (2022)

Letter Respiratory System

A longitudinal analysis of pneumococcal vaccine serotypes in pneumonia patients in Germany

Christina Bahrs, Miriam Kesselmeier, Martin Kolditz, Santiago Ewig, Gernot Rohde, Grit Barten-Neiner, Jan Rupp, Martin Witzenrath, Tobias Welte, Mathias W. Pletz

EUROPEAN RESPIRATORY JOURNAL (2022)

Article Immunology

Persistent T-Cell Reactivity in a Seronegative Patient after SARS-CoV-2 Infection and One Vaccination

Nico Andreas, Sebastian Weis, Steffi Kolanos, Sabine Baumgart, Thomas Kamradt, Mathias W. Pletz

Summary: In this case report, a 64-year-old male participant of the CoNAN study was found to have a mild SARS-CoV-2 infection without any measurable antibody response. After vaccination with the ChAdOx1 vaccine 11 months later, no antibodies were detected in six serological tests. However, T-helper cell immunity, specifically SARS-CoV-2-specific Th cells, produced detectable amounts of IFN gamma and TNF six weeks after the infection. A robust T-cell immunity was detectable for at least six months after the infection and was further boosted by the vaccination. These findings suggest that assessing prior infection or vaccine response based solely on antibody detection may have limitations in individual patients.

VACCINES (2022)

Article Microbiology

Hepatitis E, Schistosomiasis and Echinococcosis-Prevalence in a Cohort of Pregnant Migrants in Germany and Their Influence on Fetal Growth Restriction

Janine Zoellkau, Juliane Ankert, Mathias W. Pletz, Sasmita Mishra, Gregor Seliger, Silvia M. Lobmaier, Clarissa U. Prazeres Da Costa, Vera Seidel, Katharina von Weizsaecker, Alexandra Jablonka, Christian Dopfer, Michael Baier, Thomas Horvatits, Ingrid Reiter-Owona, Tanja Groten, Benjamin T. Schleenvoigt

Summary: No increased risk of HEV exposure or serological signs of schistosomiasis or echinococcosis exposure could be observed in pregnant migrants in Germany. The anti-HEV serology status did not have an influence on fetal growth restriction.

PATHOGENS (2022)

Article Microbiology

WGS-Based Phenotyping and Molecular Characterization of the Resistome, Virulome and Plasmid Replicons in Klebsiella pneumoniae Isolates from Powdered Milk Produced in Germany

Gamal Wareth, Jorg Linde, Philipp Hammer, Mathias W. Pletz, Heinrich Neubauer, Lisa D. Sprague

Summary: The emergence of Klebsiella pneumoniae (K. pneumoniae) in German healthcare is concerning, as little is known about its presence in veterinary settings and food chains. This study investigated the antibiotic susceptibility and genomic determinants of 24 K. pneumoniae strains isolated from powdered milk samples produced in Germany. The findings revealed susceptibility to most antibiotics tested, but resistance to certain antibiotics was observed, along with the presence of genes associated with antimicrobial resistance and virulence. This poses a potential threat to public health, especially for neonates and infants consuming powdered milk.

MICROORGANISMS (2022)

Review Microbiology

Brucellosis in Humans and Animals in Kyrgyzstan

Kalysbek Kydyshov, Nurbolot Usenbaev, Almaz Sharshenbekov, Narynbek Aitkuluev, Murat Abdyraev, Salamat Chegirov, Jarkynay Kazybaeva, Hanka Brangsch, Falk Melzer, Heinrich Neubauer, Mathias W. Pletz

Summary: Brucellosis is still a challenge in developing countries like Kyrgyzstan, but the introduction of mass vaccination has contributed to its control.

MICROORGANISMS (2022)

Letter Respiratory System

Impact of the COVID-19 pandemic on influenza and respiratory syncytial virus antibody titres in the community: a prospective cohort study in Neustadt, Thuringia, Germany

Mathias W. Pletz, Ralf Duerrwald, Janine Reiche, Norman Rose, Andre Scherag, Sebastian Weis

EUROPEAN RESPIRATORY JOURNAL (2022)

Review Microbiology

Towards a Harmonized Terminology: A Glossary for Biocide Susceptibility Testing

Szilvia Neuhaus, Andrea T. Fessler, Ralf Dieckmann, Lara Thieme, Mathias W. Pletz, Stefan Schwarz, Sascha Al Dahouk

Summary: Disinfection is crucial in reducing infections, but the excessive use of disinfectants may contribute to antimicrobial resistance. However, there is currently no consensus on this matter. The lack of standardized procedures and criteria to evaluate bacterial susceptibility to disinfectants makes data analysis challenging. Therefore, standardization and adaptation of evaluation concepts are urgently needed.

PATHOGENS (2022)

Article Chemistry, Physical

Comparison of bacteria in different metabolic states by micro-Raman spectroscopy

Haodong Shen, Petra Roesch, Lara Thieme, Mathias W. Pletz, Juergen Popp

Summary: It was found that different metabolic states of bacteria contribute to the formation of biofilms, and there are differences in their chemical composition. Micro-Raman spectroscopy was used to compare and investigate five species of bacteria in exponential phase, stationary phase, and biofilm. Spectral differences revealed variations in chemical composition among different metabolic states. Additionally, different species and strains of bacteria exhibited distinct behaviors based on spectral differences and principal component analysis. Furthermore, a combination of principal component analysis and support vector machines was applied to distinguish bacterial species within the same metabolic states. This study provides valuable data for comparing bacteria in different metabolic states using micro-Raman spectroscopy and chemometrics models.

JOURNAL OF MOLECULAR STRUCTURE (2023)

Article Multidisciplinary Sciences

Mathematical modeling of pneumococcal transmission dynamics in response to PCV13 infant vaccination in Germany predicts increasing IPD burden due to serotypes included in next-generation PCVs

Matthias Horn, Christian Theilacker, Ralf Sprenger, Christof von Eiff, Ernestine Mahar, Julia Schiffner-Rohe, Mathias W. Pletz, Mark van der Linden, Markus Scholz

Summary: Two next-generation pneumococcal conjugate vaccines (PCV15 and PCV20) have been licensed for use in adults, and PCV15 has also been licensed in children. A transmission model specific for Germany was developed to predict the prevalence of carriage and invasive pneumococcal disease (IPD) for serotypes included in these vaccines. The model predicts that the introduction of next-generation PCVs in adults may prevent a substantial and increasing proportion of adult IPDs, with PCV20 offering the broadest protection against pneumococcal disease.

PLOS ONE (2023)

Article Infectious Diseases

Biocide Susceptibility and Antimicrobial Resistance of Escherichia coli Isolated from Swine Feces, Pork Meat and Humans in Germany

David Attuy Vey da Silva, Ralf Dieckmann, Oliwia Makarewicz, Anita Hartung, Astrid Bethe, Mirjam Grobbel, Vitaly Belik, Mathias W. Pletz, Sascha Al Dahouk, Szilvia Neuhaus

Summary: Phenotypic susceptibility testing of ESBL and non-ESBL E. coli isolated from various sources showed differences in susceptibility to biocides and antimicrobials, with weakly positive correlations observed between biocide MICs/MBCs and antimicrobial MICs.

ANTIBIOTICS-BASEL (2023)

Letter Respiratory System

Streptococcus pneumoniae re-emerges as a cause of community-acquired pneumonia, including frequent co-infection with SARS-CoV-2, in Germany, 2021

Juliane Ankert, Stefan Hagel, Claudia Schwarz, Kaijie Pan, Liz Wang, Christof von Eiff, Bradford D. Gessner, Christian Theilacker, Mathias W. Pletz

ERJ OPEN RESEARCH (2023)

Article Infectious Diseases

Early treatment response to piperacillin/tazobactam in patients with bloodstream infections caused by non-ESBL ampicillin/sulbactam-resistant Escherichia coli: a binational cohort study

Selma Tobudic, Christina Bahrs, Lisa Schneider, Emilia Paulussen, Lucie Bartonickova, Stefan Hagel, Peter Starzengruber, Heinz Burgmann, Mathias W. W. Pletz

Summary: This study aimed to compare treatment outcomes for bloodstream infections caused by a piperacillin/tazobactam-susceptible E. coli among three patient groups. The results showed that patients with BSI caused by AMP/SLB-resistant isolates treated with another monotherapy had an enhanced early treatment response compared to those treated with PIP/TAZ, indicating a potential association between initial use of PIP/TAZ and reduced treatment response.

INFECTION (2023)

Article Infectious Diseases

Acinetobacter baumannii Global Clone-Specific Resistomes Explored in Clinical Isolates Recovered from Egypt

Samira M. Hamed, Walid F. Elkhatib, Hanka Brangsch, Ahmed S. Gesraha, Shawky Moustafa, Dalia F. Khater, Mathias W. Pletz, Lisa D. Sprague, Heinrich Neubauer, Gamal Wareth

Summary: The genomic epidemiology and resistome structure of 46 A. baumannii clinical isolates were studied, revealing the extensive presence of resistance genes and their distribution among different global clones (GCs) in Egypt. This data is crucial for understanding A. baumannii infections and the dissemination of resistance genes.

ANTIBIOTICS-BASEL (2023)

Review Infectious Diseases

Lenacapavir: A novel injectable HIV-1 capsid inhibitor

Allison M. Hitchcock, Wesley D. Kufel, Keri A. Mastro Dwyer, Eric F. Sidman

Summary: Lenacapavir is a novel HIV-1 treatment option for patients with multidrug-resistant (MDR) HIV-1 infection. It has a favorable pharmacokinetic profile and has shown good tolerability and efficacy in clinical trials.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2024)

Article Infectious Diseases

Characterization and outcomes of difficult-to-treat patients starting modern first-line ART regimens: Data from the ICONA cohort

Roberta Gagliardini, Alessandro Tavelli, Stefano Rusconi, Sergio Lo Caputo, Vincenzo Spagnuolo, Maria Mercedes Santoro, Andrea Costantini, Alessandra Vergori, Franco Maggiolo, Andrea Giacomelli, Giulia Burastero, Giordano Madeddu, Eugenia Quiros Roldan, Antonella d'Arminio Monforte, Andrea Antinori, Alessandro Cozzi-Lepri

Summary: This study evaluated multiple treatment failures to modern antiretroviral therapy in HIV-infected individuals and found that approximately 4% of them were difficult to treat. The difficult to treat group, compared to the non-difficult to treat group, was characterized by older age, higher prevalence of AIDS, lower CD4+ cell count, and higher risk of treatment failure.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2024)